0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Breast Cancer Diagnostic and Drug Technologies Market Insights, Forecast to 2028
Published Date: February 2022
|
Report Code: QYRE-Auto-26D9461
Home | Market Reports | Health | Health Conditions | Cancer
Global Breast Cancer Diagnostic and Drug Technologies Market Insights Forecast to 2028

Global Breast Cancer Diagnostic and Drug Technologies Market Insights, Forecast to 2028

Code: QYRE-Auto-26D9461
Report
February 2022
Pages:97
QYResearch
Description
Table of Content
Tables & Figures
Breast cancer is a malignant tumor that occurs in the epithelial tissue of the breast gland.Breast Cancer Diagnostic and Drug Technologies include mammography, biopsy and so on.
Market Analysis and Insights: Global Breast Cancer Diagnostic and Drug Technologies Market

The global Breast Cancer Diagnostic and Drug Technologies market size is projected to reach US$ 19060 million by 2028, from US$ 16050 million in 2021, at a CAGR of 2.0% during 2022-2028.

Fully considering the economic change by this health crisis, Mammography accounting for % of the Breast Cancer Diagnostic and Drug Technologies global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Ductal Carcinoma of Breast segment is altered to an % CAGR throughout this forecast period.
China Breast Cancer Diagnostic and Drug Technologies market size is valued at US$ million in 2021, while the North America and Europe Breast Cancer Diagnostic and Drug Technologies are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Breast Cancer Diagnostic and Drug Technologies landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Breast Cancer Diagnostic and Drug Technologies market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Breast Cancer Diagnostic and Drug Technologies market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Breast Cancer Diagnostic and Drug Technologies market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Breast Cancer Diagnostic and Drug Technologies market.
Global Breast Cancer Diagnostic and Drug Technologies Scope and Market Size
Breast Cancer Diagnostic and Drug Technologies market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Breast Cancer Diagnostic and Drug Technologies market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Mammography
Biopsy
Other

Segment by Application

Ductal Carcinoma of Breast
Invasive Ductal Carcinoma
Lobular Carcinoma
Triple Negative Breast Cancer

BY COMPANY

Abbott
Roche
BioMerieux
Becton Dickinson
GE Healthcare
Hologic
Philips
PerkinElmer
Quest Diagnostics

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Breast Cancer Diagnostic and Drug Technologies Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Mammography
1.2.3 Biopsy
1.2.4 Other
1.3 Market by Application
1.3.1 Global Breast Cancer Diagnostic and Drug Technologies Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Ductal Carcinoma of Breast
1.3.3 Invasive Ductal Carcinoma
1.3.4 Lobular Carcinoma
1.3.5 Triple Negative Breast Cancer
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Breast Cancer Diagnostic and Drug Technologies Market Perspective (2017-2028)
2.2 Breast Cancer Diagnostic and Drug Technologies Growth Trends by Region
2.2.1 Breast Cancer Diagnostic and Drug Technologies Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Breast Cancer Diagnostic and Drug Technologies Historic Market Size by Region (2017-2022)
2.2.3 Breast Cancer Diagnostic and Drug Technologies Forecasted Market Size by Region (2023-2028)
2.3 Breast Cancer Diagnostic and Drug Technologies Market Dynamics
2.3.1 Breast Cancer Diagnostic and Drug Technologies Industry Trends
2.3.2 Breast Cancer Diagnostic and Drug Technologies Market Drivers
2.3.3 Breast Cancer Diagnostic and Drug Technologies Market Challenges
2.3.4 Breast Cancer Diagnostic and Drug Technologies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Breast Cancer Diagnostic and Drug Technologies Players by Revenue
3.1.1 Global Top Breast Cancer Diagnostic and Drug Technologies Players by Revenue (2017-2022)
3.1.2 Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Players (2017-2022)
3.2 Global Breast Cancer Diagnostic and Drug Technologies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Breast Cancer Diagnostic and Drug Technologies Revenue
3.4 Global Breast Cancer Diagnostic and Drug Technologies Market Concentration Ratio
3.4.1 Global Breast Cancer Diagnostic and Drug Technologies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Breast Cancer Diagnostic and Drug Technologies Revenue in 2021
3.5 Breast Cancer Diagnostic and Drug Technologies Key Players Head office and Area Served
3.6 Key Players Breast Cancer Diagnostic and Drug Technologies Product Solution and Service
3.7 Date of Enter into Breast Cancer Diagnostic and Drug Technologies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Breast Cancer Diagnostic and Drug Technologies Breakdown Data by Type
4.1 Global Breast Cancer Diagnostic and Drug Technologies Historic Market Size by Type (2017-2022)
4.2 Global Breast Cancer Diagnostic and Drug Technologies Forecasted Market Size by Type (2023-2028)
5 Breast Cancer Diagnostic and Drug Technologies Breakdown Data by Application
5.1 Global Breast Cancer Diagnostic and Drug Technologies Historic Market Size by Application (2017-2022)
5.2 Global Breast Cancer Diagnostic and Drug Technologies Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Breast Cancer Diagnostic and Drug Technologies Market Size (2017-2028)
6.2 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Type
6.2.1 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2017-2022)
6.2.2 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2023-2028)
6.2.3 North America Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2017-2028)
6.3 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Application
6.3.1 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2017-2022)
6.3.2 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2023-2028)
6.3.3 North America Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2017-2028)
6.4 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Country
6.4.1 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2017-2022)
6.4.2 North America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Breast Cancer Diagnostic and Drug Technologies Market Size (2017-2028)
7.2 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Type
7.2.1 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2017-2022)
7.2.2 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2023-2028)
7.2.3 Europe Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2017-2028)
7.3 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Application
7.3.1 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2017-2022)
7.3.2 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2023-2028)
7.3.3 Europe Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2017-2028)
7.4 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Country
7.4.1 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2017-2022)
7.4.2 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size (2017-2028)
8.2 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Type
8.2.1 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2017-2028)
8.3 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Application
8.3.1 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2017-2028)
8.4 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Region
8.4.1 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size (2017-2028)
9.2 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Type
9.2.1 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2017-2022)
9.2.2 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2023-2028)
9.2.3 Latin America Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2017-2028)
9.3 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Application
9.3.1 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2017-2022)
9.3.2 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2023-2028)
9.3.3 Latin America Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2017-2028)
9.4 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Country
9.4.1 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2017-2022)
9.4.2 Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size (2017-2028)
10.2 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Type
10.2.1 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Share by Type (2017-2028)
10.3 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Application
10.3.1 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Share by Application (2017-2028)
10.4 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Country
10.4.1 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Breast Cancer Diagnostic and Drug Technologies Introduction
11.1.4 Abbott Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2017-2022)
11.1.5 Abbott Recent Developments
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Breast Cancer Diagnostic and Drug Technologies Introduction
11.2.4 Roche Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2017-2022)
11.2.5 Roche Recent Developments
11.3 BioMerieux
11.3.1 BioMerieux Company Details
11.3.2 BioMerieux Business Overview
11.3.3 BioMerieux Breast Cancer Diagnostic and Drug Technologies Introduction
11.3.4 BioMerieux Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2017-2022)
11.3.5 BioMerieux Recent Developments
11.4 Becton Dickinson
11.4.1 Becton Dickinson Company Details
11.4.2 Becton Dickinson Business Overview
11.4.3 Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Introduction
11.4.4 Becton Dickinson Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2017-2022)
11.4.5 Becton Dickinson Recent Developments
11.5 GE Healthcare
11.5.1 GE Healthcare Company Details
11.5.2 GE Healthcare Business Overview
11.5.3 GE Healthcare Breast Cancer Diagnostic and Drug Technologies Introduction
11.5.4 GE Healthcare Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2017-2022)
11.5.5 GE Healthcare Recent Developments
11.6 Hologic
11.6.1 Hologic Company Details
11.6.2 Hologic Business Overview
11.6.3 Hologic Breast Cancer Diagnostic and Drug Technologies Introduction
11.6.4 Hologic Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2017-2022)
11.6.5 Hologic Recent Developments
11.7 Philips
11.7.1 Philips Company Details
11.7.2 Philips Business Overview
11.7.3 Philips Breast Cancer Diagnostic and Drug Technologies Introduction
11.7.4 Philips Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2017-2022)
11.7.5 Philips Recent Developments
11.8 PerkinElmer
11.8.1 PerkinElmer Company Details
11.8.2 PerkinElmer Business Overview
11.8.3 PerkinElmer Breast Cancer Diagnostic and Drug Technologies Introduction
11.8.4 PerkinElmer Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2017-2022)
11.8.5 PerkinElmer Recent Developments
11.9 Quest Diagnostics
11.9.1 Quest Diagnostics Company Details
11.9.2 Quest Diagnostics Business Overview
11.9.3 Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Introduction
11.9.4 Quest Diagnostics Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2017-2022)
11.9.5 Quest Diagnostics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Global Breast Cancer Diagnostic and Drug Technologies Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Mammography
    Table 3. Key Players of Biopsy
    Table 4. Key Players of Other
    Table 5. Global Breast Cancer Diagnostic and Drug Technologies Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Breast Cancer Diagnostic and Drug Technologies Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Breast Cancer Diagnostic and Drug Technologies Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Region (2017-2022)
    Table 9. Global Breast Cancer Diagnostic and Drug Technologies Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Region (2023-2028)
    Table 11. Breast Cancer Diagnostic and Drug Technologies Market Trends
    Table 12. Breast Cancer Diagnostic and Drug Technologies Market Drivers
    Table 13. Breast Cancer Diagnostic and Drug Technologies Market Challenges
    Table 14. Breast Cancer Diagnostic and Drug Technologies Market Restraints
    Table 15. Global Breast Cancer Diagnostic and Drug Technologies Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Breast Cancer Diagnostic and Drug Technologies Revenue Share by Players (2017-2022)
    Table 17. Global Top Breast Cancer Diagnostic and Drug Technologies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Diagnostic and Drug Technologies as of 2021)
    Table 18. Ranking of Global Top Breast Cancer Diagnostic and Drug Technologies Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Breast Cancer Diagnostic and Drug Technologies Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Breast Cancer Diagnostic and Drug Technologies Product Solution and Service
    Table 22. Date of Enter into Breast Cancer Diagnostic and Drug Technologies Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Type (2017-2022)
    Table 26. Global Breast Cancer Diagnostic and Drug Technologies Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Type (2023-2028)
    Table 28. Global Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Breast Cancer Diagnostic and Drug Technologies Revenue Share by Application (2017-2022)
    Table 30. Global Breast Cancer Diagnostic and Drug Technologies Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Breast Cancer Diagnostic and Drug Technologies Revenue Share by Application (2023-2028)
    Table 32. North America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Breast Cancer Diagnostic and Drug Technologies Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Abbott Company Details
    Table 63. Abbott Business Overview
    Table 64. Abbott Breast Cancer Diagnostic and Drug Technologies Product
    Table 65. Abbott Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2017-2022) & (US$ Million)
    Table 66. Abbott Recent Developments
    Table 67. Roche Company Details
    Table 68. Roche Business Overview
    Table 69. Roche Breast Cancer Diagnostic and Drug Technologies Product
    Table 70. Roche Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2017-2022) & (US$ Million)
    Table 71. Roche Recent Developments
    Table 72. BioMerieux Company Details
    Table 73. BioMerieux Business Overview
    Table 74. BioMerieux Breast Cancer Diagnostic and Drug Technologies Product
    Table 75. BioMerieux Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2017-2022) & (US$ Million)
    Table 76. BioMerieux Recent Developments
    Table 77. Becton Dickinson Company Details
    Table 78. Becton Dickinson Business Overview
    Table 79. Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Product
    Table 80. Becton Dickinson Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2017-2022) & (US$ Million)
    Table 81. Becton Dickinson Recent Developments
    Table 82. GE Healthcare Company Details
    Table 83. GE Healthcare Business Overview
    Table 84. GE Healthcare Breast Cancer Diagnostic and Drug Technologies Product
    Table 85. GE Healthcare Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2017-2022) & (US$ Million)
    Table 86. GE Healthcare Recent Developments
    Table 87. Hologic Company Details
    Table 88. Hologic Business Overview
    Table 89. Hologic Breast Cancer Diagnostic and Drug Technologies Product
    Table 90. Hologic Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2017-2022) & (US$ Million)
    Table 91. Hologic Recent Developments
    Table 92. Philips Company Details
    Table 93. Philips Business Overview
    Table 94. Philips Breast Cancer Diagnostic and Drug Technologies Product
    Table 95. Philips Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2017-2022) & (US$ Million)
    Table 96. Philips Recent Developments
    Table 97. PerkinElmer Company Details
    Table 98. PerkinElmer Business Overview
    Table 99. PerkinElmer Breast Cancer Diagnostic and Drug Technologies Product
    Table 100. PerkinElmer Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2017-2022) & (US$ Million)
    Table 101. PerkinElmer Recent Developments
    Table 102. Quest Diagnostics Company Details
    Table 103. Quest Diagnostics Business Overview
    Table 104. Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Product
    Table 105. Quest Diagnostics Revenue in Breast Cancer Diagnostic and Drug Technologies Business (2017-2022) & (US$ Million)
    Table 106. Quest Diagnostics Recent Developments
    Table 107. Research Programs/Design for This Report
    Table 108. Key Data Information from Secondary Sources
    Table 109. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Type: 2021 VS 2028
    Figure 2. Mammography Features
    Figure 3. Biopsy Features
    Figure 4. Other Features
    Figure 5. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Application: 2021 VS 2028
    Figure 6. Ductal Carcinoma of Breast Case Studies
    Figure 7. Invasive Ductal Carcinoma Case Studies
    Figure 8. Lobular Carcinoma Case Studies
    Figure 9. Triple Negative Breast Cancer Case Studies
    Figure 10. Breast Cancer Diagnostic and Drug Technologies Report Years Considered
    Figure 11. Global Breast Cancer Diagnostic and Drug Technologies Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 12. Global Breast Cancer Diagnostic and Drug Technologies Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 13. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Region: 2021 VS 2028
    Figure 14. Global Breast Cancer Diagnostic and Drug Technologies Market Share by Players in 2021
    Figure 15. Global Top Breast Cancer Diagnostic and Drug Technologies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Breast Cancer Diagnostic and Drug Technologies as of 2021)
    Figure 16. The Top 10 and 5 Players Market Share by Breast Cancer Diagnostic and Drug Technologies Revenue in 2021
    Figure 17. North America Breast Cancer Diagnostic and Drug Technologies Market Size YoY (2017-2028) & (US$ Million)
    Figure 18. North America Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Type (2017-2028)
    Figure 19. North America Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Application (2017-2028)
    Figure 20. North America Breast Cancer Diagnostic and Drug Technologies Market Size Share by Country (2017-2028)
    Figure 21. United States Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Canada Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Breast Cancer Diagnostic and Drug Technologies Market Size YoY (2017-2028) & (US$ Million)
    Figure 24. Europe Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Type (2017-2028)
    Figure 25. Europe Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Application (2017-2028)
    Figure 26. Europe Breast Cancer Diagnostic and Drug Technologies Market Size Share by Country (2017-2028)
    Figure 27. Germany Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. France Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. U.K. Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Italy Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Russia Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Nordic Countries Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Asia-Pacific Breast Cancer Diagnostic and Drug Technologies Market Size YoY (2017-2028) & (US$ Million)
    Figure 34. Asia Pacific Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Type (2017-2028)
    Figure 35. Asia Pacific Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Application (2017-2028)
    Figure 36. Asia Pacific Breast Cancer Diagnostic and Drug Technologies Market Size Share by Region (2017-2028)
    Figure 37. China Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Japan Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. South Korea Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Southeast Asia Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. India Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Australia Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 43. Latin America Breast Cancer Diagnostic and Drug Technologies Market Size YoY (2017-2028) & (US$ Million)
    Figure 44. Latin America Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Type (2017-2028)
    Figure 45. Latin America Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Application (2017-2028)
    Figure 46. Latin America Breast Cancer Diagnostic and Drug Technologies Market Size Share by Country (2017-2028)
    Figure 47. Mexico Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Brazil Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size YoY (2017-2028) & (US$ Million)
    Figure 50. Middle East and Africa Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Type (2017-2028)
    Figure 51. Middle East and Africa Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Application (2017-2028)
    Figure 52. Middle East and Africa Breast Cancer Diagnostic and Drug Technologies Market Size Share by Country (2017-2028)
    Figure 53. Turkey Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. Saudi Arabia Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. UAE Breast Cancer Diagnostic and Drug Technologies Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 56. Abbott Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2017-2022)
    Figure 57. Roche Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2017-2022)
    Figure 58. BioMerieux Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2017-2022)
    Figure 59. Becton Dickinson Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2017-2022)
    Figure 60. GE Healthcare Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2017-2022)
    Figure 61. Hologic Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2017-2022)
    Figure 62. Philips Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2017-2022)
    Figure 63. PerkinElmer Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2017-2022)
    Figure 64. Quest Diagnostics Revenue Growth Rate in Breast Cancer Diagnostic and Drug Technologies Business (2017-2022)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc
SIMILAR REPORTS
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Cervical Cancer Molecular Diagnostics Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-34X5672
Tue Feb 20 00:00:00 UTC 2024

Add to Cart

Global Squamous Cell Carcinoma Antigen Quantitative Determination Kit Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-9X8498
Tue Feb 20 00:00:00 UTC 2024

Add to Cart

Global Breast Cancer Molecular Diagnostics Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-23F5603
Tue Feb 20 00:00:00 UTC 2024

Add to Cart

Global Pancreatic Cancer Molecular Diagnostics Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-32K5763
Tue Feb 20 00:00:00 UTC 2024

Add to Cart